Almirall recognized Constantia Tobepal for EKLIRA

Constantia Tobepal has been recognized by Almirall with the delivery of the unit of sale number 24 of the new inhaler against the EPOC which was launched in September 2012.

This content was submitted directly to this website by the supplier.

Almirall commented that Constantia Tobepal is a crucial partner in the success of the launch of this new and innovative pharmaceutical product. Constantia Tobepal has attended Almirall from the development to the finished product regarding packaging design and technical/machinability tests. The inhaler is packed in an Overwrap Foil with the structure PET/Alu/PE.

This new product is a further success of the more than 20 years business relationship between Almirall and Constantia Tobepal.

Companies in this article
More in Home